Activity of Antioxidative Enzymes in Erythrocytes after a Single Dose Administration of Doxorubicin in Rats Pretreated with Fullerenol C₆₀(OH)₂₄

REFERENCES

• E. Beutler. (1975). Red cell metabolism: a manual of Biochemical Methods 2nd ed, Grune & Straton, New York.
   Google Scholar
• G. Bogdanovic, V. Kojic, A. Djordjevic, J. Canadanovic-Brunet, M. Vojinovic-Miloradov, and V. V. Baltic. (2004). Modulating activity of fullerenol C60(OH)22 on doxorubicin-induced cytotoxicity. Toxicol. in Vitro 18:629–638.
   PubMed Web of Science ®Google Scholar
• A. Djordjevic. (2002). Bioloski aktivni derivati fulerena C₆₀. Zaduzbina Andrejevic, Belgrade.
   Google Scholar
• A. Djordjevic, J. Canadanovic-Brunet, M. Vojinovic-Miloradov, and G. Bogdanovic. (2005). Antioxidant properties and hypothetical radical mechanism of fullerenol C60(OH)24. Oxid. Commun 27:806–811.
   Google Scholar
• V. Djordjevic-Milic, A. Djordjevic, S. Dobric, R. Injac, D. Vuckovic, K. Stankov, V. Dragojevic-Simic, and L. J. Suvajdzic. (2006). Influence of fullerenol C60(OH)24 on doxorubicin induced cardiotoxicity in rats. Mater. Sci. Forum 518:525–529.
   Google Scholar
• D. A. Gewirtz. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57:727–741.
   PubMed Web of Science ®Google Scholar
• R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, and H. J Cohen. (2005). Haematology: Basic Principles and Practice. 4th ed, Churchill Livingston, Philadelphia, PA.
   Google Scholar
• I. Icevic, A. Djordjevic, D. Strbac, and V. Djordjevic-Milic. (2006). Fullerol polidentate ligand. Tehnika 2:7–10.
   Google Scholar
• R. Jeyaseelan, C. Poizat, R. K. Baker, S. Abdishoo, L. B. Isterabadi, G. E. Lyons, and L Kedes. (1997). A novel cardiac-restricted target for doxorubicin CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J. Biol. Chem. 272:22800–22808.
   PubMed Web of Science ®Google Scholar
• R. A. McPherson, and M. R. Pincus. (2007). Henry's Clinical Diagnosis and Management by Laboratory Methods; Philadelphia, W. B. Saunders, pp. 459–460.
   Google Scholar
• P. Menna, G. Minotti, and E. Salvatorelli. (2007). In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity. Cell. Biol. Toxil. 23:49–62.
   PubMed Web of Science ®Google Scholar
• G. Minotti, P. Menna, E. Salvatorelly, G. Cairo, and L. Gianni. (2004). The anthracyclines: molecular advances and pharmacological developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56:185–229.
   PubMed Web of Science ®Google Scholar
• S. Mirkov, A. Djordjevic, N. Andric, S. Andric, T. Kostic, G. Bogdanovic, M. Vojinovic-Miloradov, and R. Kovacevic. (2004). Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60(OH)24. Nitric Oxide-Biol. Ch. 11:201–207.
   PubMed Web of Science ®Google Scholar
• F. Misiti, B. Giardina, A. Mordente, and M. E. Clementi. (2003). The secondary alcohol and aglycone metabolites of doxorubicin alter metabolism of human erythrocytes. Braz. J. Med. Biol. Res. 36:1643–1651.
   PubMed Web of Science ®Google Scholar
• Y. Miyamoto, Y. H. Koh, Y. S. Park, N. Fujiwara, H. Sakiyama, Y. Misonou, T. Ookawara, K. Suzuki, K. Honke, and N. Taniguchi. (2003). Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol. Chem. 384:567–574.
   PubMed Web of Science ®Google Scholar
• J. R. Muñoz-Castañeda, J. Muntane, M. C. Muñoz, I. Bujalance, P. Montilla, and I. Túnez. (2006). Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol. Lett. 160:196–203.
   PubMed Web of Science ®Google Scholar
• G. P. Murphy, W., Jr. Lawrence, and R. E. Lenhard. (1995). American Society Textbook of Clinical Oncology 2nd ed. Georgia, Atlanta, American Cencer Society.
   Google Scholar
• A. Skladanowski, and J. Konopa. (1994a). Interstrand DNA crosslinking induced by anthracyclines in tumour cells. Biochem. Pharmacol. 47:2269–2278.
   PubMed Web of Science ®Google Scholar
• A. Skladanowski, and J. Konopa. (1994b). Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity. Biochem. Pharmacol. 47:2279–2287.
   PubMed Web of Science ®Google Scholar
• S. Trajkovic, S. Dobric, A. Djordjevic, V. Dragojevic-Simic, and Z. Milovanovic. (2005). Radioprotective efficiency of fullerenol in irradiated mice. Mater. Sci. Forum 494:549–554.
   Google Scholar
• S. Vaidyanthan, and M. Boroujerdi. (2000). Interaction of dexrazoxane with red blood cells and hemoglobin alters pharmacokinetics of doxorubicin. Cancer Chemother. Pharmacol. 46:93–100.
   PubMed Web of Science ®Google Scholar
• Wilson, and Gilsvold's. (1998). Texbook of Organic Medicinal and Pharmaceutical Chemistry Remers W. A. 1998. Antineoplastic Agents In Wilson and Gilsvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. 3rd Ed.. J. N. Delgado, O. Gilsvold, and W. A. Remers. 343–402. Lippincott-Raven, Philadephia.
   Google Scholar
• S. Zhou, A. Starkov, M. K. Froberg, R. L. Leino, and K. B. Wallace. (2001). Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res. 61:771–777.
   PubMed Web of Science ®Google Scholar